• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Daclizumab to prevent rejection after cardiac transplantation.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Daclizumab to prevent rejection after cardiac transplantation.

Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med. 2005 Jun 30; 352(26):2705-13.

View in: PubMed

subject areas
  • Adolescent
  • Adrenal Cortex Hormones
  • Adult
  • Aged
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Cyclosporine
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Graft Rejection
  • Heart Transplantation
  • Humans
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Logistic Models
  • Male
  • Middle Aged
  • Mycophenolic Acid
  • Opportunistic Infections
  • Survival Analysis

authors with profiles
  • Adrian B. Van Bakel